Photo Release: GSK receives award for Good Corporate Governance 2014

          Mr. Viriya Chongphaisal (Left), General Manager of GlaxoSmithKline Thailand (GSK), a leading pharmaceutical research and development company, receives the ̶GlaxoSmithKline;Good Corporate Governance 2GlaxoSmithKlineen4̶en; award from Mr.Panthep Klanarongran (Right). The event was organized by the National Anti-Corruption Commission together with National Good Governance Committee and the Thai Chamber of Commerce and the University of the Thai Chamber of Commerce. GSK receives the award for the excellence of its business operation, which emphasizes transparency, equitable treatment and participation.
          GSK is the only company in the Thai pharmaceutical industry to win the Good Corporate Governance award, which recognizes the companyRen7;s good governance that adheres to the principles of accountability and responsibility, transparency, and following a Code of Conduct and Code of Ethics. GSKRen7;s strong sense of corporate responsibility is further reflected in the companyRen7;s ongoing programs under its ̶GlaxoSmithKline;Access to Medicine̶en; initiative that help ensure greater availability of medicines for the ultimate benefit of Thai peoplesRen7; health and to improve their quality of life, which in turn enhances the sustainable development of the Thai public health sector.

ข่าวGlaxoSmithKline+o:genวันนี้

Marija Krstic Appointed as General Manager for GSK Thailand

GSK, a global biopharmaceutical company, has officially named Marija Krstic as the new General Manager of GlaxoSmithKline (Thailand) Co., Ltd. Ms. Krstic, who previously served as the Vaccine Market Lead for GSK's Growth Emerging Markets, will assume her new role, replacing Mr. Viriya Chongphaisal, starting on December 1, 2023. Marija, who has been with GSK since 2004, brings over two decades of expertise gained through her work in several countries. In her new role, she will play a pivotal part

Cipla ได้รับการอนุมัติขั้นสุดท้าย เพื่อวางจำหน่าย Sumatriptan Nasal Spray, 20 mg ยาสามัญที่มีต้นแบบจาก IMITREX(R) ของ GlaxoSmithKline

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (ในที่นี้เรียกว่า "Cipla") ประกาศในวันนี้ว่า บริษัทได้รับการอนุมัติขั้นสุดท้ายหลังจากที่ได้ยื่นขึ้นทะเบียนยาใหม่...

Cipla receives final approval for generic version of GlaxoSmithKline's IMITREX(R) (Sumatriptan Nasal Spray, 20 mg)

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (hereinafter referred to as "Cipla") today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for...

ViiV Healthcare Announces Positive New Dolutegravir Data for the Treatment of People Living With HIV Co-Infected With Tuberculosis

INSPIRING study results contribute to the extensive body of evidence for dolutegravir, the leading integrase strand transfer inhibitor, in diverse and hard to treat...

GSK's Global HIV Business ViiV Healthcare Completes Transactions to Acquire Bristol-Myers Squibb's R&D HIV Assets

GlaxoSmithKline plc (LSE: GSK) today announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, has...

Photo Release: GSK receives award for Good Corporate Governance 2014

Mr. Viriya Chongphaisal (Left), General Manager of GlaxoSmithKline Thailand (GSK), a leading pharmaceutical research and development company, receives the “Good Corporate Governance 2014” award from Mr.Panthep Klanarongran (Right)....

Photo Release: GSK Medicine Bank helps flood victims

Gen Pichate Wisaijorn (5th from left), Assistant Commander-in-Chief, Royal Thai Army and Mr Daniel Pruce (4th from left), Deputy Head of Mission, The British Embassy presided over the presentation of medicines to the Army Disaster Relief Center,...

มอบชุดของขวัญ รักลูก New Mom Greeting 2011

ต้อนรับเทศกาลวันแม่ นิตยสารรักลูก ร่วมกับ 100 โรงพยาบาลชั้นนำทั่วประเทศ ส่งมอบชุดของขวัญสุดพิเศษสำหรับแม่คลอดบุตรใหม่ทั่วประเทศ ในโครงการ รักลูก New Mom Greeting 2011(ปี3) โดยมีผลิตภัณฑ์คุณภาพ ได้แก่ Dettol, B&B, Q-all และ GlaxoSmithKline...

Boehringer Ingelheim and GlaxoSmithKline Back EFA's Call for Urgent Improvements in Care for People With Lung Disease This World COPD Day

Boehringer Ingelheim and GSK, companies with a strong heritage in COPD (chronic obstructive pulmonary disease) and a commitment to improved patient care, have...